ACVR2A and colorectal carcinoma: Second, our results implicate that mutated biomarkers ACVR2A and RYR3 are more frequently mutated in CRC when compared to EC, whereas SEC31A seems to be mutated by the same frequency in both CRC and EC MSI samples.